StonvexLoading…
StonvexStonvexStonvexCore line items from RHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.38B | $5.80B | $6.39B | $7.24B |
Operating Income | $76.46M | $241.47M | $464.59M | $890.61M |
Net Income | $132.99M | $251.60M | $411.15M | $657.92M |
EPS (Diluted) | $1.33 | $2.44 | $3.88 | $6.03 |
Total Assets | $2.86B | $2.85B | $3.01B | $2.96B |
Total Liabilities | $1.58B | $1.48B | $1.42B | $1.40B |
Cash & Equivalents | $464.44M | $537.58M | $731.74M | $658.63M |
Free Cash Flow OCF − CapEx | $266.81M | $354.15M | $591.01M | $622.63M |
Shares Outstanding | 101.14M | 102.20M | 105.21M | 107.70M |